theory clinical_2_7
imports Main

begin

typedecl entity
typedecl event

consts
  SyntheticLethality :: "entity ⇒ bool"
  Occurs :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  CoOccurrence :: "entity ⇒ bool"
  GeneticEvents :: "entity ⇒ bool"
  Multiple :: "entity ⇒ bool"
  Loss :: "entity ⇒ bool"
  BRCA2 :: "entity ⇒ bool"
  Results :: "event ⇒ bool"
  Death :: "event ⇒ bool"
  Cells :: "entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Inability :: "event ⇒ bool"
  Repair :: "event ⇒ bool"
  DNA :: "entity ⇒ bool"
  Damage :: "entity ⇒ bool"
  Pathways :: "entity ⇒ bool"
  PARPInhibitors :: "entity ⇒ bool"
  Cause :: "event ⇒ bool"
  Breaks :: "entity ⇒ bool"
  DoubleStrand :: "entity ⇒ bool"
  ReplicationAssociated :: "entity ⇒ bool"
  Prevent :: "event ⇒ bool"
  SingleStrand :: "entity ⇒ bool"
  Break :: "entity ⇒ bool"
  Force :: "event ⇒ bool"
  Rely :: "event ⇒ bool"
  HomologousRecombination :: "event ⇒ bool"
  Defective :: "event ⇒ bool"
  NonHomologousEndJoining :: "event ⇒ bool"
  ErrorProne :: "event ⇒ bool"
  Context :: "entity ⇒ bool"
  Mechanism :: "entity ⇒ bool"
  Singular :: "entity ⇒ bool"
  Cumulative :: "entity ⇒ bool"
  Primary :: "entity ⇒ bool"
  Compromised :: "entity ⇒ bool"
  Lead :: "event ⇒ bool"
  Reliance :: "event ⇒ bool"
  Increased :: "event ⇒ bool"
  Mechanisms :: "entity ⇒ bool"
  Alternative :: "entity ⇒ bool"
  Patients :: "entity ⇒ bool"
  Inhibition :: "entity ⇒ bool"
  PARP1 :: "entity ⇒ bool"
  Benefit :: "event ⇒ bool"

(* Explanation 1: Synthetic lethality occurs when the co-occurrence of multiple genetic events, such as the loss of BRCA2, results in cell death due to the inability to repair DNA damage through multiple pathways. *)
axiomatization where
  explanation_1: "∃x y z e1 e2 e3 e4. SyntheticLethality x ∧ Occurs e1 ∧ Agent e1 x ∧ CoOccurrence y ∧ GeneticEvents y ∧ Multiple y ∧ Loss z ∧ BRCA2 z ∧ Results e2 ∧ Agent e2 y ∧ Death e3 ∧ Cells z ∧ Patient e3 z ∧ Inability e4 ∧ Repair e4 ∧ DNA w ∧ Damage w ∧ Pathways v ∧ Multiple v"

(* Explanation 2: PARP inhibitors cause replication-associated double strand breaks by preventing single strand break repair, which forces cells to rely on defective homologous recombination repair and error-prone non-homologous end joining to repair DNA. *)
axiomatization where
  explanation_2: "∃x y z e1 e2 e3 e4 e5. PARPInhibitors x ∧ Cause e1 ∧ Agent e1 x ∧ Breaks y ∧ DoubleStrand y ∧ ReplicationAssociated y ∧ Prevent e2 ∧ Agent e2 x ∧ Repair e3 ∧ SingleStrand z ∧ Break z ∧ Force e3 ∧ Agent e3 x ∧ Cells w ∧ Rely e4 ∧ Agent e4 w ∧ Repair e5 ∧ HomologousRecombination e5 ∧ Defective e5 ∧ NonHomologousEndJoining e5 ∧ ErrorProne e5 ∧ DNA v"

(* Explanation 3: In the context of BRCA2 loss, synthetic lethality causes cells to rely on a singular mechanism to repair cumulative DNA damage, as the primary repair pathways are compromised, leading to an increased reliance on alternative repair mechanisms. *)
axiomatization where
  explanation_3: "∃x y z e1 e2 e3 e4 e5. BRCA2 x ∧ Loss x ∧ Context y ∧ SyntheticLethality z ∧ Cause e1 ∧ Agent e1 z ∧ Cells w ∧ Rely e2 ∧ Agent e2 w ∧ Mechanism v ∧ Singular v ∧ Repair e3 ∧ DNA u ∧ Damage u ∧ Cumulative u ∧ Pathways t ∧ Primary t ∧ Compromised t ∧ Lead e4 ∧ Agent e4 t ∧ Reliance e5 ∧ Increased e5 ∧ Mechanisms s ∧ Alternative s"

theorem hypothesis:
  assumes asm: "Patients x ∧ Loss y ∧ BRCA2 y ∧ Inhibition z ∧ PARP1 z"
  (* Hypothesis: Patients with loss of BRCA2 may benefit from PARP1 inhibition due to synthetic lethality causing cells to rely on a singular mechanism to repair cumulative damage to DNA *)
  shows "∃x y z e1 e2 e3. Patients x ∧ Loss y ∧ BRCA2 y ∧ Inhibition z ∧ PARP1 z ∧ Benefit e1 ∧ Agent e1 x ∧ Patient e1 z ∧ SyntheticLethality e2 ∧ Cause e2 e3 ∧ Cells y ∧ Rely e3 ∧ Agent e3 y ∧ Mechanism z ∧ Singular z ∧ Repair e3 ∧ Damage w ∧ Cumulative w ∧ DNA w"
  sledgehammer
  oops

end
